Miller Michael Patrick
- SEC CIK
- 0001236514
In the past year, 1 open-market sale filing worth $97.2K and no purchases.
Current role at each company
- PBYI Puma Biotechnology, Inc.Directoras of Jun 15, 2026
- RIGL Rigel Pharmaceuticals IncDirectoras of May 19, 2026
- BTAIQ BioXcel Therapeutics, Inc.Directoras of Jan 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $97.2K
- 1 filing
- Net
- −$97.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Miller Michael Patrick as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PBYI Puma Biotechnology, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 (view filing) | Nov 11 | 2 days | Miller Michael PatrickDirector | SSale | −20.0K | $4.86 | −$97.2K | −27.0%54.0K after | |
| Aug 13, 2024 (view filing) | Aug 12 | 1 day | Miller Michael PatrickDirector | SSale | −23.4K | $3.49 | −$81.5K | −33.2%47.0K after | |
| Nov 9, 2023 (view filing) | Nov 7 | 2 days | Miller Michael PatrickDirector | SSale | −25.0K | $2.83 | −$70.8K | −36.6%43.4K after | |
| Jun 15, 2023 (view filing) | Jun 13 | 2 days | Miller Michael PatrickDirector | SSale | −13.5K | $3.45 | −$46.6K | −24.6%41.4K after | 10b5-1 |
| Aug 10, 2022 (view filing) | Aug 9 | 1 day | Miller Michael PatrickDirector | SSale | −25.0K | $3.55 | −$88.8K | −31.3%54.9K after | |
| Mar 17, 2022 (view filing) | Mar 16 | 1 day | Miller Michael PatrickDirector | SSale | −25.7K | $2.80 | −$71.8K | −32.7%52.9K after |